Quanterix Corporation (QTRX)
USD 5.84
(-6.04%)
USD 5.84
(-6.04%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -132.95 Million USD | 54.87% |
| 2022 | -294.63 Million USD | 21.34% |
| 2021 | -374.57 Million USD | -148.41% |
| 2020 | -150.78 Million USD | -48.57% |
| 2019 | -101.49 Million USD | -168.46% |
| 2018 | -37.8 Million USD | 46.22% |
| 2017 | -70.3 Million USD | -261.85% |
| 2016 | -19.42 Million USD | -362.43% |
| 2015 | 7.4 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -7.42 Million USD | -53.72% |
| 2024 Q1 | -4.83 Million USD | 96.37% |
| 2023 Q1 | -285.07 Million USD | 3.25% |
| 2023 FY | -132.95 Million USD | 54.87% |
| 2023 Q4 | -132.95 Million USD | 16.31% |
| 2023 Q3 | -158.86 Million USD | 44.49% |
| 2023 Q2 | -286.16 Million USD | -0.38% |
| 2022 Q1 | -328.86 Million USD | 12.2% |
| 2022 Q3 | -300.78 Million USD | 4.65% |
| 2022 FY | -294.63 Million USD | 21.34% |
| 2022 Q2 | -315.46 Million USD | 4.08% |
| 2022 Q4 | -294.63 Million USD | 2.04% |
| 2021 Q2 | -400.53 Million USD | 2.82% |
| 2021 Q4 | -374.57 Million USD | 3.09% |
| 2021 Q3 | -386.53 Million USD | 3.49% |
| 2021 FY | -374.57 Million USD | -148.41% |
| 2021 Q1 | -412.15 Million USD | -173.34% |
| 2020 Q2 | -57.98 Million USD | 11.74% |
| 2020 Q3 | -142.18 Million USD | -145.19% |
| 2020 Q4 | -150.78 Million USD | -6.05% |
| 2020 Q1 | -65.7 Million USD | 35.26% |
| 2020 FY | -150.78 Million USD | -48.57% |
| 2019 Q3 | -105.68 Million USD | -64.09% |
| 2019 Q4 | -101.49 Million USD | 3.97% |
| 2019 Q2 | -64.4 Million USD | -144.66% |
| 2019 Q1 | -26.32 Million USD | 30.37% |
| 2019 FY | -101.49 Million USD | -168.46% |
| 2018 Q3 | -44.83 Million USD | 15.19% |
| 2018 FY | -37.8 Million USD | 46.22% |
| 2018 Q2 | -52.86 Million USD | 6.87% |
| 2018 Q1 | -56.76 Million USD | 19.25% |
| 2018 Q4 | -37.8 Million USD | 15.68% |
| 2017 FY | -70.3 Million USD | -261.85% |
| 2017 Q2 | -17.02 Million USD | -10.93% |
| 2017 Q3 | -9.36 Million USD | 45.0% |
| 2017 Q4 | -70.3 Million USD | -650.91% |
| 2017 Q1 | -15.34 Million USD | 21.02% |
| 2016 Q4 | -19.42 Million USD | 0.0% |
| 2016 FY | -19.42 Million USD | -362.43% |
| 2015 FY | 7.4 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 590.946% |
| BrainsWay Ltd. | -10.32 Million USD | -1188.353% |
| Cerus Corporation | 84.35 Million USD | 257.623% |
| Envoy Medical, Inc. | -3.81 Million USD | -3386.051% |
| electroCore, Inc. | -9.95 Million USD | -1235.59% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -2494.302% |
| IceCure Medical Ltd | -9.93 Million USD | -1238.414% |
| Inogen, Inc. | -103.56 Million USD | -28.376% |
| OrthoPediatrics Corp. | -9.26 Million USD | -1334.747% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -3551.689% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | -915.176% |
| MaxCyte, Inc. | -27.76 Million USD | -378.904% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -2487.692% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -22992.327% |
| Orthofix Medical Inc. | 96.44 Million USD | 237.863% |
| PAVmed Inc | 29.08 Million USD | 557.12% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | -684.922% |
| RxSight, Inc. | -6.68 Million USD | -1890.389% |
| Sight Sciences, Inc. | -102.71 Million USD | -29.444% |
| SI-BONE, Inc. | 5.72 Million USD | 2424.034% |
| TELA Bio, Inc. | -3.94 Million USD | -3266.878% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 331.953% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 37872.159% |
| Acutus Medical, Inc. | 12.27 Million USD | 1182.808% |
| Talis Biomedical Corporation | -57.06 Million USD | -132.998% |
| Spectral AI, Inc. | -3.5 Million USD | -3697.715% |
| Nano-X Imaging Ltd. | -48.02 Million USD | -176.84% |
| CVRx, Inc. | -59.95 Million USD | -121.759% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 6801.022% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 10506.555% |
| Bioventus Inc. | 372.51 Million USD | 135.692% |
| Venus Concept Inc. | 74.3 Million USD | 278.945% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -1205.814% |
| LivaNova PLC | 62.53 Million USD | 312.624% |
| 908 Devices Inc. | -115.09 Million USD | -15.519% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 141.458% |
| Nemaura Medical Inc. | 9.92 Million USD | 1439.625% |
| NeuroPace, Inc. | 54.33 Million USD | 344.691% |
| LENSAR, Inc. | -18.31 Million USD | -626.07% |
| Apyx Medical Corporation | -5.15 Million USD | -2481.208% |
| Cutera, Inc. | 288.3 Million USD | 146.118% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 1869.235% |
| BioSig Technologies, Inc. | 262 Thousand USD | 50847.328% |
| Anika Therapeutics, Inc. | -43.83 Million USD | -203.349% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -1345.353% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 109.461% |
| Axonics, Inc. | -77.19 Million USD | -72.239% |
| Outset Medical, Inc. | 67.67 Million USD | 296.454% |
| IRIDEX Corporation | -4.28 Million USD | -3000.7% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 25.312% |
| IRadimed Corporation | -47.71 Million USD | -178.626% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -4293.853% |
| INVO Bioscience, Inc. | 8.45 Million USD | 1673.256% |
| Telesis Bio, Inc. | 32.63 Million USD | 507.409% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -5213.788% |
| Varex Imaging Corporation | 316.9 Million USD | 141.956% |
| Quipt Home Medical Corp. | 81.73 Million USD | 262.671% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -4679.224% |
| Pulmonx Corporation | -42.36 Million USD | -213.876% |
| Dynatronics Corporation | 6.2 Million USD | 2243.09% |
| Modular Medical, Inc. | -8.04 Million USD | -1553.295% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -2994.205% |
| Semler Scientific, Inc. | -57.13 Million USD | -132.729% |
| InMode Ltd. | -135.39 Million USD | 1.799% |
| Bruker Corporation | 891.3 Million USD | 114.917% |
| Cytosorbents Corporation | 4.18 Million USD | 3279.281% |
| DexCom, Inc. | 2.02 Billion USD | 106.557% |
| Align Technology, Inc. | -840.47 Million USD | 84.181% |
| Viveve Medical, Inc. | -13.81 Million USD | -862.557% |
| ZimVie Inc. | 450.41 Million USD | 129.519% |
| Movano Inc. | -5.86 Million USD | -2166.587% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 1.114% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -22992.327% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 6801.022% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 137.264% |
| Profound Medical Corp. | -18.17 Million USD | -631.402% |
| Insulet Corporation | 798.1 Million USD | 116.659% |
| enVVeno Medical Corporation | -2.21 Million USD | -5894.5% |
| Surmodics, Inc. | -12.01 Million USD | -1006.692% |
| iCAD, Inc. | -21.2 Million USD | -526.894% |
| Nuwellis, Inc. | -2.81 Million USD | -4616.495% |
| Biotricity, Inc. | 23.09 Million USD | 675.757% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 241.972% |
| Aethlon Medical, Inc. | -4.5 Million USD | -2853.531% |
| InspireMD, Inc. | -8.04 Million USD | -1552.679% |
| PAVmed Inc. | 29.08 Million USD | 557.12% |
| BIOLASE, Inc. | 11.34 Million USD | 1272.056% |
| Beyond Air, Inc. | 6.22 Million USD | 2234.5% |
| FONAR Corporation | -14.66 Million USD | -806.615% |
| AxoGen, Inc. | 32.26 Million USD | 512.068% |
| Vivani Medical, Inc. | 42 Thousand USD | 316666.667% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -1147.495% |
| Inari Medical, Inc. | -7.16 Million USD | -1756.696% |
| UFP Technologies, Inc. | 40.77 Million USD | 426.085% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 4432.821% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -2686.614% |
| Tenon Medical, Inc. | -1.25 Million USD | -10494.263% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -1648.067% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -1014.829% |
| AdaptHealth Corp. | 2.21 Billion USD | 105.996% |
| Sintx Technologies, Inc. | 905 Thousand USD | 14791.492% |
| NanoVibronix, Inc. | -3.27 Million USD | -3956.071% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -4679.224% |
| Sensus Healthcare, Inc. | -22.36 Million USD | -494.491% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 117.64% |
| TransMedics Group, Inc. | 121.13 Million USD | 209.761% |
| ReWalk Robotics Ltd. | -26.18 Million USD | -407.861% |
| NeuroMetrix, Inc. | -1.49 Million USD | -8816.952% |
| Hyperfine, Inc. | -75.61 Million USD | -75.826% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 187.364% |
| Biomerica, Inc. | -3.38 Million USD | -3827.858% |
| Bone Biologics Corporation | -3.02 Million USD | -4293.027% |
| AVITA Medical, Inc. | -26.23 Million USD | -406.862% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -7132.224% |
| Silk Road Medical, Inc | 64.42 Million USD | 306.383% |